| Primary |
| Ovulation Induction |
19.8% |
| In Vitro Fertilisation |
17.4% |
| Infertility |
13.0% |
| Product Used For Unknown Indication |
9.7% |
| Assisted Fertilisation |
9.2% |
| Weight Control |
5.3% |
| Ovarian Disorder |
4.3% |
| Weight Decreased |
3.9% |
| Infertility Female |
3.4% |
| Artificial Insemination By Partner |
2.9% |
| Cryptorchism |
1.9% |
| Obesity |
1.9% |
| Ovarian Hyperstimulation Syndrome |
1.9% |
| Hypogonadism |
1.4% |
| Growth Retardation |
1.0% |
| Medical Diet |
1.0% |
| Anaesthesia |
0.5% |
| Diabetes Insipidus |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Hypothalamo-pituitary Disorders |
0.5% |
|
| Ovarian Torsion |
9.5% |
| Pleural Effusion |
9.5% |
| White Blood Cell Count Increased |
9.5% |
| Pulmonary Embolism |
7.9% |
| Drug Ineffective |
4.8% |
| No Adverse Event |
4.8% |
| Pancreatitis Acute |
4.8% |
| Poor Quality Drug Administered |
4.8% |
| Twin Pregnancy |
4.8% |
| Urticaria |
4.8% |
| Vomiting |
4.8% |
| Weight Increased |
4.8% |
| Abdominal Pain |
3.2% |
| Eosinophilic Pneumonia Acute |
3.2% |
| Leukaemia |
3.2% |
| Melanoma Recurrent |
3.2% |
| Myocardial Infarction |
3.2% |
| Nausea |
3.2% |
| Ovarian Enlargement |
3.2% |
| Ovarian Hyperstimulation Syndrome |
3.2% |
|
| Secondary |
| Ovulation Induction |
20.6% |
| Product Used For Unknown Indication |
17.1% |
| In Vitro Fertilisation |
16.2% |
| Infertility |
10.2% |
| Ill-defined Disorder |
5.1% |
| Ovarian Hyperstimulation Syndrome |
4.8% |
| Anovulatory Cycle |
4.2% |
| Assisted Fertilisation |
3.9% |
| Ovarian Disorder |
3.7% |
| Luteal Phase Deficiency |
2.5% |
| Infertility Male |
2.3% |
| Infertility Female |
2.1% |
| Anaesthesia |
1.4% |
| Prophylaxis |
1.4% |
| Oocyte Donation |
1.2% |
| Artificial Insemination By Partner |
0.7% |
| Drug Therapy |
0.7% |
| Hormone Therapy |
0.7% |
| Hypothalamo-pituitary Disorder |
0.7% |
| Ovarian Failure |
0.7% |
|
| Ovarian Hyperstimulation Syndrome |
28.8% |
| Ectopic Pregnancy |
16.3% |
| Pleural Effusion |
6.7% |
| Ovarian Torsion |
4.8% |
| Pregnancy |
4.8% |
| Vomiting |
4.8% |
| Loss Of Consciousness |
3.8% |
| Twin Pregnancy |
3.8% |
| Abortion Spontaneous |
2.9% |
| Pulmonary Mass |
2.9% |
| Renal Disorder |
2.9% |
| Abdominal Cavity Drainage |
1.9% |
| Abdominal Pain |
1.9% |
| Ascites |
1.9% |
| Deep Vein Thrombosis |
1.9% |
| Drug Exposure During Pregnancy |
1.9% |
| Hyponatraemia |
1.9% |
| Hypoxia |
1.9% |
| Paralysis |
1.9% |
| Premature Baby |
1.9% |
|
| Concomitant |
| In Vitro Fertilisation |
16.8% |
| Ovulation Induction |
15.6% |
| Anovulatory Cycle |
13.9% |
| Product Used For Unknown Indication |
13.4% |
| Amenorrhoea |
5.5% |
| Polycystic Ovaries |
5.3% |
| Transplant |
4.3% |
| Headache |
4.1% |
| Rheumatoid Arthritis |
2.9% |
| Acromegaly |
2.6% |
| Infertility |
2.6% |
| Ovarian Disorder |
1.9% |
| Weight Decreased |
1.9% |
| Contraception |
1.4% |
| Hypertension |
1.4% |
| Hypogonadism Male |
1.4% |
| Assisted Fertilisation |
1.2% |
| Dyspepsia |
1.2% |
| Hypothyroidism |
1.2% |
| Premature Labour |
1.2% |
|
| Ovarian Hyperstimulation Syndrome |
15.0% |
| Abortion |
13.0% |
| Twin Pregnancy |
13.0% |
| Abortion Complete |
8.0% |
| Abortion Spontaneous Complete |
6.0% |
| Premature Labour |
5.0% |
| Unintended Pregnancy |
5.0% |
| Abortion Missed |
4.0% |
| Abortion Spontaneous |
4.0% |
| Premature Baby |
4.0% |
| Maternal Exposure During Pregnancy |
3.0% |
| Premature Delivery |
3.0% |
| Premature Rupture Of Membranes |
3.0% |
| Blood Growth Hormone Increased |
2.0% |
| Chest Pain |
2.0% |
| Drug Exposure During Pregnancy |
2.0% |
| Drug Exposure Via Breast Milk |
2.0% |
| Ovarian Disorder |
2.0% |
| Ovarian Haemorrhage |
2.0% |
| Petechiae |
2.0% |
|
| Interacting |
| In Vitro Fertilisation |
61.5% |
| Ovulation Induction |
15.4% |
| Blood Testosterone Decreased |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Weight Control |
7.7% |
|
| Ovarian Hyperstimulation Syndrome |
50.0% |
| Drug Interaction |
25.0% |
| Intrapartum Haemorrhage |
25.0% |
|
